ArticleVaccines2022

Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3).

Sarinya Boongird et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.